Amplify Weight Loss Drug & Treatment ETF (THNR) holdings
Top holdings
The 10 largest positions make up 62.5% of the fund, as reported on Aug 27, 2026.
Frequently asked questions
What are the top holdings of THNR?
As of Aug 27, 2026, the largest positions in Amplify Weight Loss Drug & Treatment ETF are NVO (8.9%), LLY (8.5%), 1801 (6.5%), REGN (5.9%), SRRK (5.8%).
How concentrated is THNR?
The 10 largest positions make up 62.5% of Amplify Weight Loss Drug & Treatment ETF, as reported on Aug 27, 2026.
Fund holdings are reported periodically and are a snapshot of a past date, not a live position list — what the fund holds today may differ. Weights cover only the largest positions shown, not the whole portfolio.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.